Announcements Trials
Browse Landscape

Status

Recruiting 6Active not recruiting 5Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Neoplasms 34Breast Neoplasms 34Melanoma 26Neoplasm Metastasis 24Leukemia, Myeloid, Acute 21Colorectal Neoplasms 20Prostatic Neoplasms 19Lung Neoplasms 17Multiple Myeloma 16Ovarian Neoplasms 14Recurrence 13Myelodysplastic Syndromes 13Lymphoma, Non-Hodgkin 13Squamous Cell Carcinoma of Head and Neck 12Carcinoma, Renal Cell 12Uterine Cervical Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Pancreatic Neoplasms 10Glioblastoma 10Brain Neoplasms 10Stomach Neoplasms 8Head and Neck Neoplasms 8Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Lymphoma 7Hodgkin Disease 7

Interventions

Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × HER2-positive Breast Cancer × 90 days × Clear all
NCT03738553 2026-05-04

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

University of Washington

Terminated
13 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡